Key considerations during the transition from the acute phase of the COVID-19 pandemic: a narrative review

P Rzymski, M Pokorska-Śpiewak, T Jackowska… - Vaccines, 2023 - mdpi.com
The COVID-19 pandemic has been met with an unprecedented response from the scientific
community, leading to the development, investigation, and authorization of vaccines and …

[HTML][HTML] Global impact of the first year of COVID-19 vaccination: a mathematical modelling study

OJ Watson, G Barnsley, J Toor, AB Hogan… - The Lancet infectious …, 2022 - thelancet.com
Background The first COVID-19 vaccine outside a clinical trial setting was administered on
Dec 8, 2020. To ensure global vaccine equity, vaccine targets were set by the COVID-19 …

[图书][B] Inequality kills: The unparalleled action needed to combat unprecedented inequality in the wake of COVID-19

N Ahmed, A Marriott, N Dabi, M Lowthers… - 2022 - oxfamilibrary.openrepository.com
The wealth of the world's 10 richest men has doubled since the pandemic began. The
incomes of 99% of humanity are worse off because of COVID-19. Widening economic …

Age-stratified infection fatality rate of COVID-19 in the non-elderly population

AM Pezzullo, C Axfors, DG Contopoulos-Ioannidis… - Environmental …, 2023 - Elsevier
The largest burden of COVID-19 is carried by the elderly, and persons living in nursing
homes are particularly vulnerable. However, 94% of the global population is younger than …

[HTML][HTML] Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a …

M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate… - The Lancet, 2024 - thelancet.com
Background Regular, detailed reporting on population health by underlying cause of death
is fundamental for public health decision making. Cause-specific estimates of mortality and …

Causes and costs of global COVID-19 vaccine inequity

M Ferranna - Seminars in Immunopathology, 2024 - Springer
Despite the rapid development of safe and effective COVID-19 vaccines and the widely
recognized health and economic benefits of vaccination, there exist stark differences in …

Coronavirus disease 2019 (COVID-19) pandemic across Africa: current status of vaccinations and implications for the future

OO Ogunleye, B Godman, JO Fadare, S Mudenda… - Vaccines, 2022 - mdpi.com
The introduction of effective vaccines in December 2020 marked a significant step forward in
the global response to COVID-19. Given concerns with access, acceptability, and hesitancy …

Age-specific rate of severe and critical SARS-CoV-2 infections estimated with multi-country seroprevalence studies

D Herrera-Esposito, G de Los Campos - BMC infectious diseases, 2022 - Springer
Background Knowing the age-specific rates at which individuals infected with SARS-CoV-2
develop severe and critical disease is essential for designing public policy, for infectious …

Are COVID-19 age-mortality curves for 2020 flatter in developing countries? Evidence from a cross-sectional observational study of population-level official death …

G Demombynes, D de Walque, P Gubbins… - BMJ open, 2022 - bmjopen.bmj.com
Objectives Previous studies have found a pattern of flatter COVID-19 age-mortality curves
among low-income and middle-income countries (LMICs) using only official COVID-19 …

Using mortuary and burial data to place COVID-19 in Lusaka, Zambia within a global context

RJ Sheppard, OJ Watson, R Pieciak, J Lungu… - Nature …, 2023 - nature.com
Reported COVID-19 cases and associated mortality remain low in many sub-Saharan
countries relative to global averages, but true impact is difficult to estimate given limitations …